International quality control survey of neurochemical dementia diagnostics

Currently, neurochemical dementia diagnostics (NDD) are increasingly entering routine clinical neurochemistry, offering improved early and differential diagnosis of dementias. However, there is an obvious lack of standardization in pre-analytical sample handling and systematic quality surveys. There...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuroscience letters 2006-11, Vol.409 (1), p.1-4
Hauptverfasser: Lewczuk, Piotr, Beck, Georg, Ganslandt, Oliver, Esselmann, Hermann, Deisenhammer, Florian, Regeniter, Axel, Petereit, Hela-Felicitas, Tumani, Hayrettin, Gerritzen, Andreas, Oschmann, Patrick, Schröder, Johannes, Schönknecht, Peter, Zimmermann, Klaus, Hampel, Harald, Bürger, Katharina, Otto, Markus, Haustein, Sabine, Herzog, Karin, Dannenberg, Rainer, Wurster, Ulrich, Bibl, Mirko, Maler, Juan Manuel, Reubach, Udo, Kornhuber, Johannes, Wiltfang, Jens
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4
container_issue 1
container_start_page 1
container_title Neuroscience letters
container_volume 409
creator Lewczuk, Piotr
Beck, Georg
Ganslandt, Oliver
Esselmann, Hermann
Deisenhammer, Florian
Regeniter, Axel
Petereit, Hela-Felicitas
Tumani, Hayrettin
Gerritzen, Andreas
Oschmann, Patrick
Schröder, Johannes
Schönknecht, Peter
Zimmermann, Klaus
Hampel, Harald
Bürger, Katharina
Otto, Markus
Haustein, Sabine
Herzog, Karin
Dannenberg, Rainer
Wurster, Ulrich
Bibl, Mirko
Maler, Juan Manuel
Reubach, Udo
Kornhuber, Johannes
Wiltfang, Jens
description Currently, neurochemical dementia diagnostics (NDD) are increasingly entering routine clinical neurochemistry, offering improved early and differential diagnosis of dementias. However, there is an obvious lack of standardization in pre-analytical sample handling and systematic quality surveys. Therefore, in this study, 14 laboratories in Germany, Austria, and Switzerland were given aliquots of a human cerebrospinal fluid (CSF) sample, and were asked to measure Alzheimer's disease (AD) biomarkers (amyloid β (Aβ) peptides, total Tau protein, and phosphorylated Tau protein (P-tau 181P)) according to their routine protocols. Results: The inter-laboratory coefficients of variation of the results obtained by the laboratories participating in this study were in the range of 20–30%. Although the results of this quality control survey are promising, the quality of measurements has to be further optimized.
doi_str_mv 10.1016/j.neulet.2006.07.009
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68989937</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304394006006768</els_id><sourcerecordid>68989937</sourcerecordid><originalsourceid>FETCH-LOGICAL-c444t-a5b7324d733cdba755d4bc279c950005975c91b1fcfd2b1ebe043b3566ac85c53</originalsourceid><addsrcrecordid>eNp9kMFu1DAURa0K1A6FP0AoG9glPMd2HG-QUEVLUSU2sLYc-wU8SuzWdirN3-PRjNQdq7c5976rQ8h7Ch0FOnzedwG3BUvXAwwdyA5AXZAdHWXfSiX7V2QHDHjLFIcr8ibnPQAIKvgluaISuGBK7siP-1AwBVN8DGZpnjaz-HJobAwlxaXJW3rGQxPnpj5L0f7F1dvKOVwxFG8a582fEHPxNr8lr2ezZHx3vtfk9-23Xzff24efd_c3Xx9ayzkvrRGTZD13kjHrJiOFcHyyvVRWieNCJYVVdKKznV0_UZwQOJuYGAZjR2EFuyafTr2PKT5tmItefba4LCZg3LIeRjUqxWQF-Qm0KeaccNaPya8mHTQFfXSo9_rkUB8dapC6OqyxD-f-bVrRvYTO0irw8QyYXGXMyQTr8ws39kyN0Ffuy4nDauPZY9LZegwWnU9oi3bR_3_JP4eukvk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68989937</pqid></control><display><type>article</type><title>International quality control survey of neurochemical dementia diagnostics</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Lewczuk, Piotr ; Beck, Georg ; Ganslandt, Oliver ; Esselmann, Hermann ; Deisenhammer, Florian ; Regeniter, Axel ; Petereit, Hela-Felicitas ; Tumani, Hayrettin ; Gerritzen, Andreas ; Oschmann, Patrick ; Schröder, Johannes ; Schönknecht, Peter ; Zimmermann, Klaus ; Hampel, Harald ; Bürger, Katharina ; Otto, Markus ; Haustein, Sabine ; Herzog, Karin ; Dannenberg, Rainer ; Wurster, Ulrich ; Bibl, Mirko ; Maler, Juan Manuel ; Reubach, Udo ; Kornhuber, Johannes ; Wiltfang, Jens</creator><creatorcontrib>Lewczuk, Piotr ; Beck, Georg ; Ganslandt, Oliver ; Esselmann, Hermann ; Deisenhammer, Florian ; Regeniter, Axel ; Petereit, Hela-Felicitas ; Tumani, Hayrettin ; Gerritzen, Andreas ; Oschmann, Patrick ; Schröder, Johannes ; Schönknecht, Peter ; Zimmermann, Klaus ; Hampel, Harald ; Bürger, Katharina ; Otto, Markus ; Haustein, Sabine ; Herzog, Karin ; Dannenberg, Rainer ; Wurster, Ulrich ; Bibl, Mirko ; Maler, Juan Manuel ; Reubach, Udo ; Kornhuber, Johannes ; Wiltfang, Jens</creatorcontrib><description>Currently, neurochemical dementia diagnostics (NDD) are increasingly entering routine clinical neurochemistry, offering improved early and differential diagnosis of dementias. However, there is an obvious lack of standardization in pre-analytical sample handling and systematic quality surveys. Therefore, in this study, 14 laboratories in Germany, Austria, and Switzerland were given aliquots of a human cerebrospinal fluid (CSF) sample, and were asked to measure Alzheimer's disease (AD) biomarkers (amyloid β (Aβ) peptides, total Tau protein, and phosphorylated Tau protein (P-tau 181P)) according to their routine protocols. Results: The inter-laboratory coefficients of variation of the results obtained by the laboratories participating in this study were in the range of 20–30%. Although the results of this quality control survey are promising, the quality of measurements has to be further optimized.</description><identifier>ISSN: 0304-3940</identifier><identifier>EISSN: 1872-7972</identifier><identifier>DOI: 10.1016/j.neulet.2006.07.009</identifier><identifier>PMID: 17045397</identifier><identifier>CODEN: NELED5</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Alzheimer Disease - cerebrospinal fluid ; Alzheimer Disease - diagnosis ; Alzheimer's disease ; Amyloid ; Amyloid beta-Peptides - cerebrospinal fluid ; Biological and medical sciences ; Biomarkers ; Cerebrospinal fluid ; Clinical Laboratory Techniques - standards ; Data Collection ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Diagnosis, Differential ; Europe ; Fundamental and applied biological sciences. Psychology ; Humans ; Indicators and Reagents ; Medical sciences ; Neurology ; Phosphorylation ; Quality Control ; Reproducibility of Results ; Tau ; tau Proteins - cerebrospinal fluid ; Vertebrates: nervous system and sense organs</subject><ispartof>Neuroscience letters, 2006-11, Vol.409 (1), p.1-4</ispartof><rights>2006 Elsevier Ireland Ltd</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c444t-a5b7324d733cdba755d4bc279c950005975c91b1fcfd2b1ebe043b3566ac85c53</citedby><cites>FETCH-LOGICAL-c444t-a5b7324d733cdba755d4bc279c950005975c91b1fcfd2b1ebe043b3566ac85c53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0304394006006768$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18239802$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17045397$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lewczuk, Piotr</creatorcontrib><creatorcontrib>Beck, Georg</creatorcontrib><creatorcontrib>Ganslandt, Oliver</creatorcontrib><creatorcontrib>Esselmann, Hermann</creatorcontrib><creatorcontrib>Deisenhammer, Florian</creatorcontrib><creatorcontrib>Regeniter, Axel</creatorcontrib><creatorcontrib>Petereit, Hela-Felicitas</creatorcontrib><creatorcontrib>Tumani, Hayrettin</creatorcontrib><creatorcontrib>Gerritzen, Andreas</creatorcontrib><creatorcontrib>Oschmann, Patrick</creatorcontrib><creatorcontrib>Schröder, Johannes</creatorcontrib><creatorcontrib>Schönknecht, Peter</creatorcontrib><creatorcontrib>Zimmermann, Klaus</creatorcontrib><creatorcontrib>Hampel, Harald</creatorcontrib><creatorcontrib>Bürger, Katharina</creatorcontrib><creatorcontrib>Otto, Markus</creatorcontrib><creatorcontrib>Haustein, Sabine</creatorcontrib><creatorcontrib>Herzog, Karin</creatorcontrib><creatorcontrib>Dannenberg, Rainer</creatorcontrib><creatorcontrib>Wurster, Ulrich</creatorcontrib><creatorcontrib>Bibl, Mirko</creatorcontrib><creatorcontrib>Maler, Juan Manuel</creatorcontrib><creatorcontrib>Reubach, Udo</creatorcontrib><creatorcontrib>Kornhuber, Johannes</creatorcontrib><creatorcontrib>Wiltfang, Jens</creatorcontrib><title>International quality control survey of neurochemical dementia diagnostics</title><title>Neuroscience letters</title><addtitle>Neurosci Lett</addtitle><description>Currently, neurochemical dementia diagnostics (NDD) are increasingly entering routine clinical neurochemistry, offering improved early and differential diagnosis of dementias. However, there is an obvious lack of standardization in pre-analytical sample handling and systematic quality surveys. Therefore, in this study, 14 laboratories in Germany, Austria, and Switzerland were given aliquots of a human cerebrospinal fluid (CSF) sample, and were asked to measure Alzheimer's disease (AD) biomarkers (amyloid β (Aβ) peptides, total Tau protein, and phosphorylated Tau protein (P-tau 181P)) according to their routine protocols. Results: The inter-laboratory coefficients of variation of the results obtained by the laboratories participating in this study were in the range of 20–30%. Although the results of this quality control survey are promising, the quality of measurements has to be further optimized.</description><subject>Alzheimer Disease - cerebrospinal fluid</subject><subject>Alzheimer Disease - diagnosis</subject><subject>Alzheimer's disease</subject><subject>Amyloid</subject><subject>Amyloid beta-Peptides - cerebrospinal fluid</subject><subject>Biological and medical sciences</subject><subject>Biomarkers</subject><subject>Cerebrospinal fluid</subject><subject>Clinical Laboratory Techniques - standards</subject><subject>Data Collection</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Diagnosis, Differential</subject><subject>Europe</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Indicators and Reagents</subject><subject>Medical sciences</subject><subject>Neurology</subject><subject>Phosphorylation</subject><subject>Quality Control</subject><subject>Reproducibility of Results</subject><subject>Tau</subject><subject>tau Proteins - cerebrospinal fluid</subject><subject>Vertebrates: nervous system and sense organs</subject><issn>0304-3940</issn><issn>1872-7972</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFu1DAURa0K1A6FP0AoG9glPMd2HG-QUEVLUSU2sLYc-wU8SuzWdirN3-PRjNQdq7c5976rQ8h7Ch0FOnzedwG3BUvXAwwdyA5AXZAdHWXfSiX7V2QHDHjLFIcr8ibnPQAIKvgluaISuGBK7siP-1AwBVN8DGZpnjaz-HJobAwlxaXJW3rGQxPnpj5L0f7F1dvKOVwxFG8a582fEHPxNr8lr2ezZHx3vtfk9-23Xzff24efd_c3Xx9ayzkvrRGTZD13kjHrJiOFcHyyvVRWieNCJYVVdKKznV0_UZwQOJuYGAZjR2EFuyafTr2PKT5tmItefba4LCZg3LIeRjUqxWQF-Qm0KeaccNaPya8mHTQFfXSo9_rkUB8dapC6OqyxD-f-bVrRvYTO0irw8QyYXGXMyQTr8ws39kyN0Ffuy4nDauPZY9LZegwWnU9oi3bR_3_JP4eukvk</recordid><startdate>20061127</startdate><enddate>20061127</enddate><creator>Lewczuk, Piotr</creator><creator>Beck, Georg</creator><creator>Ganslandt, Oliver</creator><creator>Esselmann, Hermann</creator><creator>Deisenhammer, Florian</creator><creator>Regeniter, Axel</creator><creator>Petereit, Hela-Felicitas</creator><creator>Tumani, Hayrettin</creator><creator>Gerritzen, Andreas</creator><creator>Oschmann, Patrick</creator><creator>Schröder, Johannes</creator><creator>Schönknecht, Peter</creator><creator>Zimmermann, Klaus</creator><creator>Hampel, Harald</creator><creator>Bürger, Katharina</creator><creator>Otto, Markus</creator><creator>Haustein, Sabine</creator><creator>Herzog, Karin</creator><creator>Dannenberg, Rainer</creator><creator>Wurster, Ulrich</creator><creator>Bibl, Mirko</creator><creator>Maler, Juan Manuel</creator><creator>Reubach, Udo</creator><creator>Kornhuber, Johannes</creator><creator>Wiltfang, Jens</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20061127</creationdate><title>International quality control survey of neurochemical dementia diagnostics</title><author>Lewczuk, Piotr ; Beck, Georg ; Ganslandt, Oliver ; Esselmann, Hermann ; Deisenhammer, Florian ; Regeniter, Axel ; Petereit, Hela-Felicitas ; Tumani, Hayrettin ; Gerritzen, Andreas ; Oschmann, Patrick ; Schröder, Johannes ; Schönknecht, Peter ; Zimmermann, Klaus ; Hampel, Harald ; Bürger, Katharina ; Otto, Markus ; Haustein, Sabine ; Herzog, Karin ; Dannenberg, Rainer ; Wurster, Ulrich ; Bibl, Mirko ; Maler, Juan Manuel ; Reubach, Udo ; Kornhuber, Johannes ; Wiltfang, Jens</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c444t-a5b7324d733cdba755d4bc279c950005975c91b1fcfd2b1ebe043b3566ac85c53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Alzheimer Disease - cerebrospinal fluid</topic><topic>Alzheimer Disease - diagnosis</topic><topic>Alzheimer's disease</topic><topic>Amyloid</topic><topic>Amyloid beta-Peptides - cerebrospinal fluid</topic><topic>Biological and medical sciences</topic><topic>Biomarkers</topic><topic>Cerebrospinal fluid</topic><topic>Clinical Laboratory Techniques - standards</topic><topic>Data Collection</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Diagnosis, Differential</topic><topic>Europe</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Indicators and Reagents</topic><topic>Medical sciences</topic><topic>Neurology</topic><topic>Phosphorylation</topic><topic>Quality Control</topic><topic>Reproducibility of Results</topic><topic>Tau</topic><topic>tau Proteins - cerebrospinal fluid</topic><topic>Vertebrates: nervous system and sense organs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lewczuk, Piotr</creatorcontrib><creatorcontrib>Beck, Georg</creatorcontrib><creatorcontrib>Ganslandt, Oliver</creatorcontrib><creatorcontrib>Esselmann, Hermann</creatorcontrib><creatorcontrib>Deisenhammer, Florian</creatorcontrib><creatorcontrib>Regeniter, Axel</creatorcontrib><creatorcontrib>Petereit, Hela-Felicitas</creatorcontrib><creatorcontrib>Tumani, Hayrettin</creatorcontrib><creatorcontrib>Gerritzen, Andreas</creatorcontrib><creatorcontrib>Oschmann, Patrick</creatorcontrib><creatorcontrib>Schröder, Johannes</creatorcontrib><creatorcontrib>Schönknecht, Peter</creatorcontrib><creatorcontrib>Zimmermann, Klaus</creatorcontrib><creatorcontrib>Hampel, Harald</creatorcontrib><creatorcontrib>Bürger, Katharina</creatorcontrib><creatorcontrib>Otto, Markus</creatorcontrib><creatorcontrib>Haustein, Sabine</creatorcontrib><creatorcontrib>Herzog, Karin</creatorcontrib><creatorcontrib>Dannenberg, Rainer</creatorcontrib><creatorcontrib>Wurster, Ulrich</creatorcontrib><creatorcontrib>Bibl, Mirko</creatorcontrib><creatorcontrib>Maler, Juan Manuel</creatorcontrib><creatorcontrib>Reubach, Udo</creatorcontrib><creatorcontrib>Kornhuber, Johannes</creatorcontrib><creatorcontrib>Wiltfang, Jens</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neuroscience letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lewczuk, Piotr</au><au>Beck, Georg</au><au>Ganslandt, Oliver</au><au>Esselmann, Hermann</au><au>Deisenhammer, Florian</au><au>Regeniter, Axel</au><au>Petereit, Hela-Felicitas</au><au>Tumani, Hayrettin</au><au>Gerritzen, Andreas</au><au>Oschmann, Patrick</au><au>Schröder, Johannes</au><au>Schönknecht, Peter</au><au>Zimmermann, Klaus</au><au>Hampel, Harald</au><au>Bürger, Katharina</au><au>Otto, Markus</au><au>Haustein, Sabine</au><au>Herzog, Karin</au><au>Dannenberg, Rainer</au><au>Wurster, Ulrich</au><au>Bibl, Mirko</au><au>Maler, Juan Manuel</au><au>Reubach, Udo</au><au>Kornhuber, Johannes</au><au>Wiltfang, Jens</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>International quality control survey of neurochemical dementia diagnostics</atitle><jtitle>Neuroscience letters</jtitle><addtitle>Neurosci Lett</addtitle><date>2006-11-27</date><risdate>2006</risdate><volume>409</volume><issue>1</issue><spage>1</spage><epage>4</epage><pages>1-4</pages><issn>0304-3940</issn><eissn>1872-7972</eissn><coden>NELED5</coden><abstract>Currently, neurochemical dementia diagnostics (NDD) are increasingly entering routine clinical neurochemistry, offering improved early and differential diagnosis of dementias. However, there is an obvious lack of standardization in pre-analytical sample handling and systematic quality surveys. Therefore, in this study, 14 laboratories in Germany, Austria, and Switzerland were given aliquots of a human cerebrospinal fluid (CSF) sample, and were asked to measure Alzheimer's disease (AD) biomarkers (amyloid β (Aβ) peptides, total Tau protein, and phosphorylated Tau protein (P-tau 181P)) according to their routine protocols. Results: The inter-laboratory coefficients of variation of the results obtained by the laboratories participating in this study were in the range of 20–30%. Although the results of this quality control survey are promising, the quality of measurements has to be further optimized.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>17045397</pmid><doi>10.1016/j.neulet.2006.07.009</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0304-3940
ispartof Neuroscience letters, 2006-11, Vol.409 (1), p.1-4
issn 0304-3940
1872-7972
language eng
recordid cdi_proquest_miscellaneous_68989937
source MEDLINE; Elsevier ScienceDirect Journals
subjects Alzheimer Disease - cerebrospinal fluid
Alzheimer Disease - diagnosis
Alzheimer's disease
Amyloid
Amyloid beta-Peptides - cerebrospinal fluid
Biological and medical sciences
Biomarkers
Cerebrospinal fluid
Clinical Laboratory Techniques - standards
Data Collection
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Diagnosis, Differential
Europe
Fundamental and applied biological sciences. Psychology
Humans
Indicators and Reagents
Medical sciences
Neurology
Phosphorylation
Quality Control
Reproducibility of Results
Tau
tau Proteins - cerebrospinal fluid
Vertebrates: nervous system and sense organs
title International quality control survey of neurochemical dementia diagnostics
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T11%3A25%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=International%20quality%20control%20survey%20of%20neurochemical%20dementia%20diagnostics&rft.jtitle=Neuroscience%20letters&rft.au=Lewczuk,%20Piotr&rft.date=2006-11-27&rft.volume=409&rft.issue=1&rft.spage=1&rft.epage=4&rft.pages=1-4&rft.issn=0304-3940&rft.eissn=1872-7972&rft.coden=NELED5&rft_id=info:doi/10.1016/j.neulet.2006.07.009&rft_dat=%3Cproquest_cross%3E68989937%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68989937&rft_id=info:pmid/17045397&rft_els_id=S0304394006006768&rfr_iscdi=true